Grace Therapeutics, Stock Forecast - 4 Period Moving Average

GRCE Stock   3.28  0.05  1.55%   
The 4 Period Moving Average forecasted value of Grace Therapeutics, on the next trading day is expected to be 3.23 with a mean absolute deviation of 0.12 and the sum of the absolute errors of 6.63. Grace Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Grace Therapeutics, stock prices and determine the direction of Grace Therapeutics,'s future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Grace Therapeutics,'s historical fundamentals, such as revenue growth or operating cash flow patterns.
  
At present, Grace Therapeutics,'s Accounts Payable is projected to increase significantly based on the last few years of reporting. The current year's Cash is expected to grow to about 26.4 M, whereas Total Stockholder Equity is forecasted to decline to about 58.7 M.
A four-period moving average forecast model for Grace Therapeutics, is based on an artificially constructed daily price series in which the value for a given day is replaced by the mean of that value and the values for four preceding and succeeding time periods. This model is best suited to forecast equities with high volatility.

Grace Therapeutics, 4 Period Moving Average Price Forecast For the 23rd of November

Given 90 days horizon, the 4 Period Moving Average forecasted value of Grace Therapeutics, on the next trading day is expected to be 3.23 with a mean absolute deviation of 0.12, mean absolute percentage error of 0.03, and the sum of the absolute errors of 6.63.
Please note that although there have been many attempts to predict Grace Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Grace Therapeutics,'s next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Grace Therapeutics, Stock Forecast Pattern

Backtest Grace Therapeutics,Grace Therapeutics, Price PredictionBuy or Sell Advice 

Grace Therapeutics, Forecasted Value

In the context of forecasting Grace Therapeutics,'s Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Grace Therapeutics,'s downside and upside margins for the forecasting period are 0.03 and 7.91, respectively. We have considered Grace Therapeutics,'s daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
3.28
3.23
Expected Value
7.91
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the 4 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Grace Therapeutics, stock data series using in forecasting. Note that when a statistical model is used to represent Grace Therapeutics, stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria107.0899
BiasArithmetic mean of the errors -0.0305
MADMean absolute deviation0.1163
MAPEMean absolute percentage error0.0396
SAESum of the absolute errors6.63
The four period moving average method has an advantage over other forecasting models in that it does smooth out peaks and troughs in a set of daily price observations of Grace Therapeutics,. However, it also has several disadvantages. In particular this model does not produce an actual prediction equation for Grace Therapeutics, and therefore, it cannot be a useful forecasting tool for medium or long range price predictions

Predictive Modules for Grace Therapeutics,

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Grace Therapeutics,. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Grace Therapeutics,'s price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.163.237.91
Details
Intrinsic
Valuation
LowRealHigh
0.153.057.73
Details

Other Forecasting Options for Grace Therapeutics,

For every potential investor in Grace, whether a beginner or expert, Grace Therapeutics,'s price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Grace Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Grace. Basic forecasting techniques help filter out the noise by identifying Grace Therapeutics,'s price trends.

Grace Therapeutics, Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Grace Therapeutics, stock to make a market-neutral strategy. Peer analysis of Grace Therapeutics, could also be used in its relative valuation, which is a method of valuing Grace Therapeutics, by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Grace Therapeutics, Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Grace Therapeutics,'s price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Grace Therapeutics,'s current price.

Grace Therapeutics, Market Strength Events

Market strength indicators help investors to evaluate how Grace Therapeutics, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Grace Therapeutics, shares will generate the highest return on investment. By undertsting and applying Grace Therapeutics, stock market strength indicators, traders can identify Grace Therapeutics, entry and exit signals to maximize returns.

Grace Therapeutics, Risk Indicators

The analysis of Grace Therapeutics,'s basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Grace Therapeutics,'s investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting grace stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Grace Therapeutics, is a strong investment it is important to analyze Grace Therapeutics,'s competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Grace Therapeutics,'s future performance. For an informed investment choice regarding Grace Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Grace Therapeutics, to cross-verify your projections.
For information on how to trade Grace Stock refer to our How to Trade Grace Stock guide.
You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Grace Therapeutics,. If investors know Grace will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Grace Therapeutics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Grace Therapeutics, is measured differently than its book value, which is the value of Grace that is recorded on the company's balance sheet. Investors also form their own opinion of Grace Therapeutics,'s value that differs from its market value or its book value, called intrinsic value, which is Grace Therapeutics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Grace Therapeutics,'s market value can be influenced by many factors that don't directly affect Grace Therapeutics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Grace Therapeutics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Grace Therapeutics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Grace Therapeutics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.